Immune Modulator Drugs Improved Survival for People Hospitalized with Covid-19
Treating adults hospitalized with Covid-19 with infliximab or abatacept—drugs widely used to treat certain autoimmune diseases—did not shorten recovery time but did substantially improve clinical status and reduced deaths, according to an ACTIV trial.
Researchers Identify High Costs of Living with SCD
Americans ages 64 and younger with commercial health insurance who live with sickle cell disease (SCD) pay almost quadruple the out-of-pocket medical costs over their lifetimes.
Study Looks at Antioxidant Effects on Dementia Risk
Some studies suggest that consuming high levels of antioxidants—compounds commonly found in vegetables and fruits that help protect cells from molecular damage—may help prevent the development of dementia.
Scientists Use Machine Learning to Better Identify Long Covid
An NIH-supported research team identified characteristics of people with long Covid and those likely to have it. Using machine learning techniques, scientists analyzed an unprecedented collection of electronic health records (EHRs) available for Covid-19 research.
Retinal Cell Map Could Advance Therapies for Blinding Diseases
An NIH discovery is shedding light on tissue targeted by age-related macular degeneration and other eye diseases. Researchers have identified distinct differences among the cells comprising a tissue in the retina that is vital to human visual perception.
Hypertension During Pregnancy Linked to Future Cardiac Events
An NIH-funded study explains factors related to increased risk for heart attack or stroke among women who had hypertension, or high blood pressure, while pregnant.
NIH Starts Clinical Trial of Epstein-Barr Vaccine
NIAID launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV).
Vision Improves with Treatment for Blinding Blood Vessel Condition
New research shows that a treatment for retinal vein occlusion (RVO) yields long-lasting vision gains, with visual acuity remaining significantly above baseline at 5 years. However, many patients require ongoing treatment.
Researchers Create 3-D Model for Rare Neuromuscular Disorders
A scientific team supported by NIH has created a tiny, bioengineered 3-D model that mimics the biology of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy, a pair of rare, devastating neuromuscular diseases.